Free Trial
EPA:DIM

Sartorius Stedim Biotech (DIM) Stock Price, News & Analysis

Sartorius Stedim Biotech logo
€201.20 -0.10 (-0.05%)
As of 04/25/2025

About Sartorius Stedim Biotech Stock (EPA:DIM)

Key Stats

Today's Range
€200.90
€204.80
50-Day Range
€152.90
€208.60
52-Week Range
N/A
Volume
69,408 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.

Receive DIM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sartorius Stedim Biotech and its competitors with MarketBeat's FREE daily newsletter.

DIM Stock News Headlines

Sartorius Stedim Biotech S.A. - Barron's
M.A.G.A. is Finished – This Could be even Better
You’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big change. Make America Wealthy Again (M.A.W.A).
RBC Capital Sticks to Its Buy Rating for Sartorius Stedim Biotech (0RG8)
Sartorius Stedim Biotech releases Universal Registration Document 2024
Sartorius Stedim Biotech Preliminary FY24 Profit Declines - Quick Facts
See More Headlines

DIM Stock Analysis - Frequently Asked Questions

Sartorius Stedim Biotech's stock was trading at €188.70 at the start of the year. Since then, DIM shares have increased by 6.6% and is now trading at €201.20.
View the best growth stocks for 2025 here
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sartorius Stedim Biotech investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Corbus Pharmaceuticals (CRBP), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX) and C3.ai (AI).

Industry, Sector and Symbol

Stock Exchange
EPA
Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Current Symbol
EPA:DIM
CIK
N/A
Fax
N/A
Employees
10,493
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (EPA:DIM) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners